Recombinant Modified Vaccinia Virus Ankara (MVA) Expressing Wild-Type Human p53 Induces Specific Antitumor CTL Expansion

The p53 gene product is an attractive target for tumor immunotherapy. The present study aims to understand the potential of MVAp53 vaccine to induce expansion of p53-specific cytotoxic T lymphocyte ex vivo in cancer patients. The result indicated that 14 of 23 cancer patients demonstrated p53-specif...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Guang-Yun, Srivastava, Tumul, Ishizaki, Hidenobu, Lacey, Simon F., Diamond, Don J., Ellenhorn, Joshua D. I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2011
Materias:
Cellular and Molecular Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260009/
https://www.ncbi.nlm.nih.gov/pubmed/21843052
http://dx.doi.org/10.3109/07357907.2011.606248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260009/
https://www.ncbi.nlm.nih.gov/pubmed/21843052
http://dx.doi.org/10.3109/07357907.2011.606248

Ejemplares similares